Answer
Long-term monitoring helps identify delayed effects, including persistent immune changes and the reported risk of secondary malignancies following CAR T-cell therapy.
Sources for this answer
- UK GovernmentUK Government · Reputable Web
- Kymriah cells dispersion for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.